表紙
市場調査レポート

圧迫治療 - 世界市場の分析と予測

MediPoint: Compression Therapy - Global Analysis and Market Forecasts

発行 GlobalData 商品コード 347869
出版日 ページ情報 英文 279 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
圧迫治療 - 世界市場の分析と予測 MediPoint: Compression Therapy - Global Analysis and Market Forecasts
出版日: 2015年10月01日 ページ情報: 英文 279 Pages
概要

圧迫治療製品、特に静的圧迫装置は、静脈の疾患 (深部静脈血栓症 (DVT) 、静脈瘤、静脈性下腿潰瘍など) やリンパ系の疾患 (原発性・続発性リンパ浮腫など) の治療における標準になってきています。

当レポートでは、世界の圧迫治療市場について調査分析し、主要10ヶ国 (米国、フランス、ドイツ、イタリア、スペイン、英国、日本、ブラジル、中国、インド) を対象に、疾患の概要、競合評価、アンメットニーズ、パイプライン製品について検証するほか、主要企業プロファイルなど、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 産業の概要

  • 概要
  • 解剖・生理
  • 臨床転帰
  • 技術の応用
  • 技術の利点と欠点
  • 市場参入
  • 臨床試験の影響
  • 規制プロセス
  • 償還
  • 規制の問題・主な取引
  • 経済の影響

第4章 アンメットニーズ

  • 概要
  • 患者教育の向上
  • 一貫した包帯法の導入
  • 介護者の教育の拡大
  • 患者の快適性を強化
  • 患者のモビリティをサポート

第5章 市場機会分析

第6章 市場促進要因と障壁

  • 促進要因
  • 障壁
  • 代替

第7章 競合評価

  • 概要
  • 技術と主な製品
  • 製品プロファイル
  • SWOT分析

第8章 パイプライン評価

  • 概要
  • 製品プロファイル

第9章 注目すべき臨床試験

  • 概要
  • 臨床試験プロファイル

第10章 現在・将来の企業

  • 概要
  • 企業プロファイル
  • その他

第11章 戦略的競合評価

  • 企業の市場シェア

第12章 市場見通し:市場セグメント別

  • 世界市場の概要
  • 地域別

第13章 市場見通し:地域別

  • 世界市場の概要
  • 地域別
  • 米国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • 英国
  • 日本
  • 中国
  • インド
  • ブラジル

第14章 付録

図表

目次
Product Code: GDME0216MAR

Compression therapy products, especially static compression devices, have become the standard in the treatment of venous conditions, such as deep vein thrombosis (DVT), varicose veins, and venous leg ulcers, and lymphatic disorders, such as primary and secondary lymphedema. While elastic stockings and compression bandaging have played important roles in providing effective therapies, newer modes of static compression such as custom garments and adjustable products have been introduced to ease patient burden and improve treatment compliance. Pneumatic compression devices have similarly advanced, despite their lower adoption rates. Segmented pumps with tunable pressure characteristics have joined the ranks of simpler devices with single outputs for single inflatable chambers in the treatment of venous and lymphatic conditions. Although pneumatic compression has not quite been an arena of rapid innovation, some manufacturers have developed advanced pump systems that deliver complex pressure profiles to the affected areas of the patients' bodies. This report focuses on both static and pneumatic compression market categories. The overall compression therapy market has been estimated in this report, which covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India (10MM) up to 2021. The report provides an investigation of unmet needs, future adoption trends and compound annual growth rates (CAGR) for each geography and market segment. In addition, this report presents the current market drivers and barriers which will influence the future market growth of compression therapy in the 10MM.

Highlights

Key Questions Answered

  • What is the current and future market outlook for compression therapy products in the developed and emerging markets? What trends are affecting the global compression therapy market?
  • Which are the key, high growth markets? What compression therapy segments are growing the fastest?
  • What are the unmet needs? What is the scope for more innovation and what are the end-users looking for in their products?
  • What are some of the newer innovations that may fulfill these unmet needs? What are the physician perceptions and market outlooks?
  • What percent of global revenue are from emerging markets? How will this change in the future?
  • Sigvaris, BSN Medical, Medi, and Medtronic currently dominate the global advanced dressings market. What are their market shares in the major global economies and which companies constitute the remainder of the market?

Reasons to buy

  • "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview
  • 3.2. Anatomy & Physiology
    • 3.2.1. Chronic Venous Disease
    • 3.2.2. Varicose Veins
    • 3.2.3. Venous Leg Ulcers
    • 3.2.4. Venous Thromboembolism and Deep Vein Thrombosis
    • 3.2.5. Lymphedema
  • 3.3. Clinical Outcomes
    • 3.3.1. Venous Conditions
    • 3.3.2. Lymphedema
  • 3.4. Applications of Technology
    • 3.4.1. Static Compression
    • 3.4.2. Pneumatic Compression Devices
  • 3.5. Advantages and Disadvantages of Technology
  • 3.6. Market Access
  • 3.7. Influence of Clinical Trials
  • 3.8. Regulatory Process
    • 3.8.1. Overview
    • 3.8.2. United States
    • 3.8.3. EU5
    • 3.8.4. Japan
    • 3.8.5. China
    • 3.8.6. India
    • 3.8.7. Brazil
  • 3.9. Reimbursement
    • 3.9.1. Overview
    • 3.9.2. United States
    • 3.9.3. France
    • 3.9.4. Germany
    • 3.9.5. Italy
    • 3.9.6. Spain
    • 3.9.7. UK
    • 3.9.8. Japan
    • 3.9.9. China
    • 3.9.10. India
    • 3.9.11. Brazil
  • 3.10. Regulatory Issue & Key Deals
    • 3.10.1. Regulatory Issues & Recalls
    • 3.10.2. Mergers, Acquisitions, and Key Partnerships
  • 3.11. Economic Impact
    • 3.11.1. Indirect Costs
    • 3.11.2. Direct Costs

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Improving Patient Education
  • 4.3. Implementing Consistent Bandaging
  • 4.4. Expanding Caregiver Education
  • 4.5. Enhancing Patient Comfort
  • 4.6. Supporting Patient Mobility

5. Market Opportunity Analysis

  • 5.1. Overview
  • 5.2. Engineering Adjustable Garments for Greater Flexibility
  • 5.3. Developing Multilayer Stockings for Easier Application
  • 5.4. Improving Compression Garments by Adding Sensors
  • 5.5. Innovating Automated Bandaging for Consistent Treatment

6. Market Drivers and Barriers

  • 6.1. Drivers
    • 6.1.1. Aging Populations
    • 6.1.2. Cancer-Related Lymphedema
    • 6.1.3. Rising Rates of Obesity
    • 6.1.4. Lymphatic Filariasis in Underdeveloped Regions
    • 6.1.5. The Need for Cost Savings
  • 6.2. Barriers
    • 6.2.1. Insufficient Reimbursement
    • 6.2.2. Patient Compliance
    • 6.2.3. Cost of Care
    • 6.2.4. Medical Device Excise Tax
    • 6.2.5. Availability of Venture Capital
  • 6.3. Substitutes
    • 6.3.1. Procedures to Prevent Thromboembolism
    • 6.3.2. Invasive and Non-invasive Interventions for Varicose Veins
    • 6.3.3. Surgical Interventions for Lymphedema
    • 6.3.4. Pharmacological Options for DVT Management

7. Competitive Assessment

  • 7.1. Overview
  • 7.2. Technology and Product Offerings
  • 7.3. Product Profile
    • 7.3.1. Covidien (Medtronic)
    • 7.3.2. Sigvaris
    • 7.3.3. BSN Medical
    • 7.3.4. Medi
    • 7.3.5. Laboratoires Innothera
    • 7.3.6. 3M Health Care
    • 7.3.7. Thuasne
    • 7.3.8. Paul Hartmann
    • 7.3.9. Mego Afek
    • 7.3.10. Medline Industries
    • 7.3.11. ArjoHuntleigh
    • 7.3.12. DJO Global
    • 7.3.13. Lohmann & Rauscher
    • 7.3.14. Venosan (Salzmann)
    • 7.3.15. Sanyleg
    • 7.3.16. Juzo
    • 7.3.17. Daesung Maref
    • 7.3.18. Bio Compression Systems
    • 7.3.19. Smith & Nephew
    • 7.3.20. Molnlycke Health Care
    • 7.3.21. Gloria Med
    • 7.3.22. B. Braun
    • 7.3.23. Alcare
    • 7.3.24. Derma Sciences
    • 7.3.25. Urgo
    • 7.3.26. Systagenix
    • 7.3.27. Muranaka Medical Instruments
    • 7.3.28. ConvaTec
    • 7.3.29. Xiamen Senyang
    • 7.3.30. Guangzhou Yihao Electronic Technology
    • 7.3.31. Talley Group
    • 7.3.32. Cardinal Health
    • 7.3.33. Tactile Medical
    • 7.3.34. Devon Medical
  • 7.4. SWOT For Each Category of Device
    • 7.4.1. SWOT, Compression Garments
    • 7.4.2. SWOT, Compression Bandages
    • 7.4.3. SWOT, Anti-Embolism Stockings
    • 7.4.4. SWOT, Pneumatic Compression Therapy

8. Pipeline Assessment

  • 8.1. Overview
  • 8.2. Product Profiles
    • 8.2.1. Medical Compression Systems: ActiveCast and ActiveCare Vascular
    • 8.2.2. Epoch Medical Systems: Adaptive Compression for Lower Limb Prosthetics
    • 8.2.3. Footfalls & Heartbeats: Compression Bandage with Textile-based Sensor

9. Clinical Trials to Watch

  • 9.1. Overview
  • 9.2. Clinical Trial Profiles
    • 9.2.1. Evaluation of a Dual Action Pneumatic Compression Device
    • 9.2.2. Treatment Response to Different Lymphedema Compression Programs Using a Pneumatic Compression Device
    • 9.2.3. Two Pneumatic Compression Devices for the Treatment of Lower Extremity Lymphedema
    • 9.2.4. A Hemodynamic Comparison Study of Stationary and Portable Pneumatic Compression Devices
    • 9.2.5. DVT Prevention Study: Geko Neurosmuscular Stimulator vs. Thromboembolism Deterrent Stockings (TEDS)
    • 9.2.6. Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
    • 9.2.7. Effectiveness of Two Compression Methods in the Treatment of Upper Limb Lymphedema
    • 9.2.8. Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphedema

10. Current and Future Players

  • 10.1. Overview
  • 10.2. Company Profiles
    • 10.2.1. Covidien (Medtronic)
    • 10.2.2. Sigvaris
    • 10.2.3. BSN Medical
    • 10.2.4. Medi
    • 10.2.5. Innothera
    • 10.2.6. 3M Health Care
    • 10.2.7. Thuasne
    • 10.2.8. Paul Hartmann
    • 10.2.9. Mego Afek
    • 10.2.10. Medline Industries
    • 10.2.11. ArjoHuntleigh (Getinge)
    • 10.2.12. DJO Global
    • 10.2.13. Lohmann & Rauscher
    • 10.2.14. Venosan (Salzmann)
    • 10.2.15. Sanyleg (Mimosa)
    • 10.2.16. Juzo
    • 10.2.17. Daesung Maref
    • 10.2.18. Bio Compression Systems
    • 10.2.19. Smith & Nephew
    • 10.2.20. Molnlycke Health Care
    • 10.2.21. Gloria Med
    • 10.2.22. B. Braun
    • 10.2.23. Alcare
    • 10.2.24. Derma Sciences
    • 10.2.25. Laboratoires Urgo
    • 10.2.26. Systagenix (Acelity)
    • 10.2.27. Muranaka Medical Instruments
    • 10.2.28. ConvaTec
    • 10.2.29. Xiamen Senyang
    • 10.2.30. Guangzhou Yihao Electronic Technology
    • 10.2.31. Talley Group
    • 10.2.32. Cardinal Health
    • 10.2.33. Tactile Medical
    • 10.2.34. Devon Medical
  • 10.3. Other Current Players

11. Strategic Competitive Assessment

  • 11.1. Company Market Share
    • 11.1.1. Overview
    • 11.1.2. Company Share by Region

12. Market Outlooks by Market Segment

  • 12.1. Global Overview
  • 12.2. By Region
    • 12.2.1. 5EU
    • 12.2.2. APAC

13. Market Outlooks by Geography

  • 13.1. Global Overview
  • 13.2. By Region
    • 13.2.1. 5EU
    • 13.2.2. APAC
  • 13.3. US
  • 13.4. France
  • 13.5. Germany
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. UK
  • 13.9. Japan
  • 13.10. China
  • 13.11. India
  • 13.12. Brazil

14. Appendix

  • 14.1. Bibliography
  • 14.2. Abbreviations
  • 14.3. Methodology
    • 14.3.1. Overview
    • 14.3.2. Coverage
    • 14.3.3. Secondary Research
  • 14.4. Forecasting Methodology
  • 14.5. Physicians and Specialists Included in This Study
    • 14.5.1. Key Opinion Leaders
    • 14.5.2. Primary Research Summary
  • 14.6. About the Authors
    • 14.6.1. Shashank Settipalli, Analyst, Medical Devices
    • 14.6.2. Priya Radhakrishnan, MBA, Director, Research and Analysis, Medical Devices
  • 14.7. About GlobalData
  • 14.8. Disclaimer

List of Tables

  • Table 1: The C Classification for Chronic Venous Conditions
  • Table 2: E, A, and P Classifications for Chronic Venous Conditions
  • Table 3: Stages of Lymphedema
  • Table 4: Sample HCPCS Codes for Compression Therapy Products
  • Table 5: Sample ICD-10 Codes for Indications That Require Compression Therapy
  • Table 6: Reimbursement Classification for Medical Devices in Japan
  • Table 7: Covidien's Compression Therapy Marketed Products
  • Table 8: Covidien's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 9: Sigvaris Compression Therapy Marketed Products
  • Table 10: Sigvaris' Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 11: BSN Medical's Compression Therapy Marketed Products
  • Table 12: BSN Medical's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 13: Medi Compression Therapy Marketed Products
  • Table 14: Medi's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 15: Innothera's Compression Therapy Marketed Products
  • Table 16: Laboratoires Innothera's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 17: 3M Health Care's Compression Therapy Marketed Products
  • Table 18: 3M Health Care's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 19: Thuasne's Compression Therapy Marketed Products
  • Table 20: Thuasne's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 21: Paul Hartmann's Compression Therapy Marketed Products
  • Table 22: Paul Hartmann Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 23: Mego Afek's Compression Therapy Marketed Products
  • Table 24: Mego Afek's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 25: Medline's Compression Therapy Marketed Products
  • Table 26: Medline Industries' Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 27: ArjoHuntleigh Compression Therapy Marketed Products
  • Table 28: ArjoHuntleigh's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 29: DJO Global's Compression Therapy Marketed Products
  • Table 30: DJO Global's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 31: Lohmann & Rauscher's Compression Therapy Marketed Products
  • Table 32: Lohmann & Rauscher's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 33: Venosan's Compression Therapy Marketed Products
  • Table 34: Venosan's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 35: Sanyleg's Compression Therapy Marketed Products
  • Table 36: Sanyleg's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 37: Juzo's Compression Therapy Marketed Products
  • Table 38: Juzo's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 39: Daesung Maref's Compression Therapy Marketed Products
  • Table 40: Daesung Maref's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 41: Bio Compressions Systems Compression Therapy Marketed Products
  • Table 42: Bio Compression Systems' Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 43: Smith & Nephew's Compression Therapy Marketed Products
  • Table 44: Smith & Nephew's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 45: Molnlycke's Health Care Compression Therapy Marketed Products
  • Table 46: Molnlycke's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 47: Gloria Med's Compression Therapy Marketed Products
  • Table 48: Gloria Med's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 49: B. Braun Compression Therapy Marketed Products
  • Table 50: B. Braun's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 51: Alcare's Compression Therapy Marketed Products
  • Table 52: Alcare Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 53: Derma Sciences' Compression Therapy Marketed Products
  • Table 54: Derma Sciences' Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 55: Urgo's Compression Therapy Marketed Products
  • Table 56: Urgo's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 57: Systagenix's Compression Therapy Marketed Products
  • Table 58: Systagenix's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 59: Muranaka's Medical Instruments Compression Therapy Marketed Products
  • Table 60: ConvaTec Compression Therapy Marketed Products
  • Table 61: ConvaTec's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 62: Xiamen Senyang's Compression Therapy Marketed Products
  • Table 63: Xiamen Senyang's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 64: Guangzhou Yihao Electronic Technology Compression Therapy Marketed Products
  • Table 65: Guangzhou Yihao's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 66: Talley Group Compression Therapy Marketed Products
  • Table 67: Talley Group's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 68: Cardinal Health's Compression Therapy Marketed Products
  • Table 69: Cardinal Health's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 70: Tactile Medical's Compression Therapy Marketed Products
  • Table 71: Tactile Medical's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 72: Devon Medical's Compression Therapy Marketed Products
  • Table 73: Devon Medical's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 74: Compression Garments SWOT Analysis, 2015
  • Table 75: Compression Bandages SWOT Analysis, 2015
  • Table 76: Anti-Embolism Stockings SWOT Analysis, 2015
  • Table 77: Pneumatic Compression Therapy SWOT Analysis, 2015
  • Table 78: Covidien (Medtronic) Company Profile
  • Table 79: Covidien (Medtronic) SWOT Analysis, 2015
  • Table 80: Sigvaris Company Profile
  • Table 81: Sigvaris SWOT Analysis, 2015
  • Table 82: BSN Medical Company Profile
  • Table 83: BSN Medical SWOT Analysis, 2015
  • Table 84: Medi Company Profile
  • Table 85: Medi SWOT Analysis, 2015
  • Table 86: Innothera Company Profile
  • Table 87: Innothera SWOT Analysis, 2015
  • Table 88: 3M Company Profile
  • Table 89: 3M SWOT Analysis, 2015
  • Table 90: Thuasne Company Profile
  • Table 91: Thuasne SWOT Analysis, 2015
  • Table 92: Paul Hartmann Company Profile
  • Table 93: Paul Hartmann SWOT Analysis, 2015
  • Table 94: Mego Afek Company Profile
  • Table 95: Mego Afek SWOT Analysis, 2015
  • Table 96: Medline Company Profile
  • Table 97: Medline SWOT Analysis, 2015
  • Table 98: ArjoHuntleigh Company Profile
  • Table 99: ArjoHuntleigh SWOT Analysis, 2015
  • Table 100: DJO Global Company Profile
  • Table 101: DJO Global SWOT Analysis, 2015
  • Table 102: Lohmann & Rauscher Company Profile
  • Table 103: Lohmann & Rauscher SWOT Analysis, 2015
  • Table 104: Venosan (Salzmann) Company Profile
  • Table 105: Venosan (Salzmann) SWOT Analysis, 2015
  • Table 106: Sanyleg (Mimosa) Company Profile
  • Table 107: Sanyleg (Mimosa) SWOT Analysis, 2015
  • Table 108: Juzo Company Profile
  • Table 109: Juzo SWOT Analysis, 2015
  • Table 110: Daesung Maref Company Profile
  • Table 111: Daesung Maref SWOT Analysis, 2015
  • Table 112: Bio Compression Systems Company Profile
  • Table 113: Bio Compression Systems SWOT Analysis, 2015
  • Table 114: Smith & Nephew Company Profile
  • Table 115: Smith & Nephew SWOT Analysis, 2015
  • Table 116: Molnlycke Company Profile
  • Table 117: Molnlycke SWOT Analysis, 2015
  • Table 118: Gloria Med Company Profile
  • Table 119: Gloria Med SWOT Analysis, 2015
  • Table 120: B. Braun Company Profile
  • Table 121: B. Braun SWOT Analysis, 2015
  • Table 122: Alcare Company Profile
  • Table 123: Alcare SWOT Analysis, 2015
  • Table 124: Derma Sciences Company Profile
  • Table 125: Derma Sciences SWOT Analysis, 2015
  • Table 126: Laboratoires Urgo Company Profile
  • Table 127: Laboratoires Urgo SWOT Analysis, 2015
  • Table 128: Systagenix Company Profile
  • Table 129: Systagenix SWOT Analysis, 2015
  • Table 130: Muranaka Medical Instruments Company Profile
  • Table 131: Muranaka Medical Instruments SWOT Analysis, 2015
  • Table 132: ConvaTec Company Profile
  • Table 133: ConvaTec SWOT Analysis, 2015
  • Table 134: Xiamen Senyang Company Profile
  • Table 135: Xiamen Senyang SWOT Analysis, 2015
  • Table 136: Guangzhou Yihao Electronic Technology Company Profile
  • Table 137: Guangzhou Yihao SWOT Analysis, 2015
  • Table 138: Talley Group Company Profile
  • Table 139: Talley Group SWOT Analysis, 2015
  • Table 140: Cardinal Health Company Profile
  • Table 141: Cardinal Health SWOT Analysis, 2015
  • Table 142: Tactile Medical Company Profile
  • Table 143: Tactile Medical SWOT Analysis, 2015
  • Table 144: Devon Medical Company Profile
  • Table 145: Devon Medical SWOT Analysis, 2015
  • Table 146: Other Current Players
  • Table 147: Global Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 148: Global Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 149: EU5 Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 150: APAC Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 151: Compression Therapy Global Market Value Forecast by Country, $m, 2011-2021
  • Table 152: US Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 153: US Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 154: France Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 155: France Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 156: Germany Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 157: Germany Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 158: Italy Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 159: Italy Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 160: Spain Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 161: Spain Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 162: UK Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 163: UK Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 164: Japan Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 165: Japan Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 166: China Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 167: China Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 168: India Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 169: India Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 170: Brazil Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 171: Brazil Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021

List of Figures

  • Figure 1: Virchow's Triad
  • Figure 2: US Company Market Shares for Static Compression Therapy, 2014
  • Figure 3: US Company Market Shares for Pneumatic Compression Therapy, 2014
  • Figure 4: 5EU Company Market Shares for Static Compression Therapy, 2014
  • Figure 5: 5EU Company Market Shares for Pneumatic Compression Therapy, 2014
  • Figure 6: APAC Company Market Shares for Static Compression Therapy, 2014
  • Figure 7: Brazil Company Market Shares for Static Compression Therapy, 2014
  • Figure 8: Global Market Value Forecast by Market Segment for Compression Therapy, 2011-2021
  • Figure 9: Global Market Value Forecast by Market Segment for Static Compression Therapy, 2011-2021
  • Figure 10: 5EU Market Value Forecast by Market Segment for Compression Therapy, 2011-2021
  • Figure 11: APAC Market Value Forecast by Market Segment for Compression Therapy, 2011-2021
  • Figure 12: Compression Therapy Global Market Value Forecast by Country, $m, 2011-2021
  • Figure 13: Compression Therapy Global Market Share Comparison by Country, 2014 and 2021
  • Figure 14: Global Pneumatic Compression Therapy Market Share Comparison by Country, 2014 and 2021
  • Figure 15: 5EU Compression Therapy Market Share Comparison by Country, 2014 and 2021
  • Figure 16: APAC Compression Therapy Market Share Comparison by Country, 2014 and 2021
  • Figure 17: US Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 18: US Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 19: France Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 20: France Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 21: Germany Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 22: Germany Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 23: Italy Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 24: Italy Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 25: Spain Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 26: Spain Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 27: UK Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 28: UK Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 29: Japan Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 30: Japan Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 31: China Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 32: China Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 33: India Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 34: India Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 35: Brazil Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 36: Brazil Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 37: Primary Research Participants By Country
Back to Top